Company CVAbout Sun Pharmaceutical Industries Ltd 
Sun Pharmaceutical Industries Ltd
Large Cap
Pharmaceuticals & Drugs
Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
Company Coordinates
Company Details
Sun Pharma Advanced Res.Centre, Tandalja Vadodara Gujarat : 390020
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 239.93 Cr
Number of Shares
239.93 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Feb-2019
239.93
239.93
6696
1
ESOP
12-Nov-2018
239.93
239.93
3600
1
ESOP
24-May-2018
239.93
239.93
1314
1
ESOP
14-Nov-2017
239.93
239.93
1260
1
ESOP
28-Sep-2017
239.93
239.93
1106
1
ESOP
11-Aug-2017
239.93
239.93
799
1
ESOP
26-May-2017
239.93
239.93
15000
1
ESOP
26-May-2017
239.93
239.93
15000
1
ESOP
14-Feb-2017
239.93
239.93
20993
1
ESOP
22-Nov-2016
240.68
240.68
16229
1
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
0.6862
Mutual Funds
Held by 43 Schemes (12.24%)
FIIs
Held by 1165 FIIs (18.05%)
Promoter with highest holding
Shanghvi Finance Private Limited (40.3%)
Highest Public shareholder
Icici Prudential Value Discovery Fund (3.26%)
Individual Investors Holdings
5.47%
Board of Directors
Management
Designation
Remuneration
Dilip S Shanghvi
Managing Director
5.45 cr
Sudhir V Valia
Non-Exec & Non-Independent Dir
19.0 lacs
Sailesh T Desai
Whole-time Director
1.97 cr
Gautam Doshi
Non-Exec. & Independent Dir.
76.0 lacs
Pawan Goenka
Lead Independent Director
85.0 lacs
Rama Bijapurkar
Independent Director
48.0 lacs
Anoop Deshpande
Company Sec. & Compli. Officer
0
Sanjay K Asher
Independent Director
21.67 lacs
Rolf Hoffmann
Independent Director
0
Aalok Shanghvi
Whole Time Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
11,883.00
95.81%
Other Operating Revenues - Others
519.92
4.19%
Pharmaceuticals
Pharmaceuticals
Other Operating Revenues - Others
Other Operating Revenues - Others
Stock DNARevenue and Profits:
Net Sales:
13,675 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2,903 Cr
Pharmaceuticals & Drugs
INR 406,003 Cr (Large Cap)
34.00
33
0.94%
-0.25
16.22%
5.73
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
